Exhibit 99.1
[EXECUTION COPY]
KOPPERS HOLDINGS INC.
1,750,000 Shares
Common Stock
($0.01 par value per Share)
Underwriting Agreement
November 27, 2006
UBS Securities LLC
299 Park Avenue
New York, New York 10171-0026
Ladies and Gentlemen:
Each person or entity identified as
a selling stockholder, in Schedule C annexed hereto
(each, a “ Selling Stockholder ”) proposes to
sell to UBS Securities LLC (“ UBS ” or the
“ Underwriter ”), an aggregate of
1,750,000 shares (the “ Firm Shares ”) of
common stock, $0.01 par value per share (the “ Common
Stock ”), of Koppers Holdings Inc. a Pennsylvania
corporation (the “ Company ”). The number of
Firm Shares to be sold by each Selling Stockholder is the number of
Firm Shares set forth opposite the name of such Selling Stockholder
in Schedule C annexed hereto. In addition, solely for
the purpose of covering over-allotments, the Selling Stockholders
propose to grant to the Underwriter the option to purchase from the
Selling Stockholders up to an additional 262,500 shares of
Common Stock (the “ Additional Shares ”). The
Firm Shares and the Additional Shares are hereinafter collectively
sometimes referred to as the “ Shares .” The
Shares are described in the Prospectus which is referred to
below.
The Company has prepared and filed,
in accordance with the provisions of the Securities Act of 1933, as
amended, and the rules and regulations thereunder (collectively,
the “ Act ”), with the Securities and Exchange
Commission (the “ Commission ”) a registration
statement on Form S-3 (File No. 333-136329) under the Act (the
“ registration statement ”), including a
prospectus, which registration statement incorporates by reference
documents which the Company has filed, or will file, in accordance
with the provisions of the Securities Exchange Act of 1934, as
amended, and the rules and regulations thereunder (collectively,
the “ Exchange Act ”). Amendments to such
registration statement, if necessary or appropriate, have been
similarly prepared and filed with the Commission in accordance with
the Act. Such registration statement, as so amended, has become
effective under the Act.
Except where the context otherwise
requires, “ Registration Statement ,” as used
herein, means the registration statement, as amended at the time of
such registration statement’s effectiveness for purposes of
Section 11 of the Act, as such section applies to the
Underwriter (the “ Effective Time ”), including
(i) all documents filed as a part thereof or incorporated or
deemed to be incorporated by reference therein, (ii) any
information contained or incorporated by reference in a prospectus
filed with the Commission pursuant to Rule 424(b) under the
Act, to the extent such information is deemed, pursuant to
Rule 430B or Rule 430C
1
[EXECUTION COPY]
under the Act, to be part of the
registration statement at the Effective Time, and (iii) any
registration statement filed to register the offer and sale of
Shares pursuant to Rule 462(b) under the Act.
Except where the context otherwise
requires, “ Pre-Pricing Prospectus ,” as used
herein, means the basic prospectus included in the Registration
Statement as of the date hereof, including all documents
incorporated by reference therein. Except where the context
otherwise requires, “ Basic Prospectus ,” as
used herein, means any such basic prospectus furnished to you by
the Company and attached to or used with the Prospectus Supplement
(as defined below).
Except where the context otherwise
requires, “ Prospectus Supplement ,” as used
herein, means the final prospectus supplement, relating to the
Shares, filed by the Company with the Commission pursuant to
Rule 424(b) under the Act on or before the second business day
after the date hereof (or such earlier time as may be required
under the Act), in the form furnished by the Company to you for use
by the Underwriter and by dealers in connection with the offering
of the Shares.
Except where the context otherwise
requires, “ Prospectus ,” as used herein, means
the Prospectus Supplement together with the Basic Prospectus
attached to or used with the Prospectus Supplement.
“ Disclosure Package
,” as used herein, means the Pre-Pricing
Prospectus.
Any reference herein to the
registration statement, the Registration Statement, the Basic
Prospectus, the Pre-Pricing Prospectus, the Prospectus Supplement
or the Prospectus shall be deemed to refer to and include the
documents, if any, incorporated by reference, or deemed to be
incorporated by reference, therein (the “ Incorporated
Documents ”), including, unless the context otherwise
requires, the documents, if any, filed as exhibits to such
Incorporated Documents. Any reference herein to the terms “
amend ,” “ amendment ” or “
supplement ” with respect to the Registration
Statement, the Basic Prospectus, the Pre-Pricing Prospectus, the
Prospectus Supplement or the Prospectus shall be deemed to refer to
and include the filing of any document under the Exchange Act on or
after the initial effective date of the Registration Statement, or
the date of the Basic Prospectus, the Pre-Pricing Prospectus, the
Prospectus Supplement or the Prospectus, and deemed to be
incorporated therein by reference.
As used in this Agreement, “
business day ” shall mean a day on which the
New York Stock Exchange (the “ NYSE ”) is
open for trading. The terms “herein,”
“hereof,” “hereto,”
“hereinafter” and similar terms, as used in this
Agreement, shall in each case refer to this Agreement as a whole
and not to any particular section, paragraph, sentence or other
subdivision of this Agreement. The term “or,” as used
herein, is not exclusive.
The Company, each of the Selling
Stockholders and the Underwriter agree as follows:
1. Sale and Purchase . Upon
the basis of the representations and warranties and subject to the
terms and conditions herein set forth, each of the Selling
Stockholders agrees to sell, in each case severally and not
jointly, to the Underwriter, and the Underwriter agrees to purchase
from each Selling Stockholder, the number of Firm Shares set forth
in Schedule B
2
[EXECUTION COPY]
annexed hereto, subject to
adjustment in accordance with Section 11 hereof, in each case
at a purchase price of $21.55 per Share. The Company is
advised by you that the Underwriter intends (i) to make a
public offering of their respective portions of the Firm Shares as
soon after the effectiveness of this Agreement as in your judgment
is advisable and (ii) initially to offer the Firm Shares upon
the terms set forth in the Prospectus. You may from time to time
increase or decrease the public offering price after the initial
public offering to such extent as you may determine.
In addition, the Selling
Stockholders, in each case severally and not jointly, hereby grant
to the Underwriter the option (the “ Over-Allotment
Option ”) to purchase, and upon the basis of the
representations and warranties and subject to the terms and
conditions herein set forth, the Underwriter shall have the right
to purchase from the Selling Stockholders all or a portion of the
Additional Shares as may be necessary to cover over-allotments made
in connection with the offering of the Firm Shares, at the same
purchase price per share to be paid by the Underwriter to the
Selling Stockholders for the Firm Shares. The Over-Allotment Option
may be exercised by the Underwriter at any time and from time to
time on or before the thirtieth day following the date of the
Prospectus Supplement, by written notice to the Selling
Stockholders. Such notice shall set forth the aggregate number of
Additional Shares as to which the Over-Allotment Option is being
exercised and the date and time when the Additional Shares are to
be delivered (any such date and time being herein referred to as an
“ additional time of purchase ”);
provided , however , that no additional time of
purchase shall be earlier than the “time of purchase”
(as defined below) nor earlier than the second business day after
the date on which the Over-Allotment Option shall have been
exercised nor later than the tenth business day after the date on
which the Over-Allotment Option shall have been exercised. The
number of Additional Shares to be sold to the Underwriter shall be
subject to adjustment in accordance with Section 11 hereof.
Upon any exercise of the Over-Allotment Option, the number of
Additional Shares to be purchased from each Selling Stockholder
shall be the number which bears the same proportion to the
aggregate number of Additional Shares being purchased as the number
of Additional Shares set forth opposite the name of such Selling
Stockholder in Schedule C annexed hereto bears to 262,500,
subject, in each case, to such adjustment as UBS may determine
solely to eliminate fractional shares.
Pursuant to Custody Agreements
between each Selling Stockholder and Mellon Investor Services LLC
dated November 27, 2006 (each, a “Custody
Agreement”), Mellon Investor Services LLC shall act as
representative of the Selling Stockholders. The foregoing
representative (the “ Representative of the Selling
Stockholders” ) is authorized to cause all or any portion
of the Shares to be transferred on the books of the Company into
such names as the Underwriter shall have instructed in writing and
to make appropriate book-entry transfers representing such Shares
for the account of the Underwriter, to receive the proceeds of the
sale of such Shares, to give receipts for such proceeds, to pay
therefrom the expenses to be borne by such Selling Stockholder in
connection with the sale and public offering of the Shares, to
distribute the balance of such proceeds to such Selling
Stockholder, to receive notices on behalf of such Selling
Stockholder and to take such other action as may be necessary or
desirable in connection with the transactions contemplated by this
Agreement.
2. Payment and Delivery.
Payment of the purchase price for the Firm Shares shall be made to
each Selling Stockholder by Federal Funds wire transfer against
delivery of the
3
[EXECUTION COPY]
certificates for the Firm Shares to
you through the facilities of The Depository Trust Company (“
DTC ”) for the account of the Underwriter. Such
payment and delivery shall be made at 10:00 A.M., New York
City time, on December 1, 2006 (unless another time shall be
agreed to by you and the Representative of the Selling Stockholders
or unless postponed in accordance with the provisions of
Section 11 hereof). The time at which such payment and
delivery are to be made is hereinafter sometimes called the “
time of purchase .” Electronic transfer of the Firm
Shares shall be made to you at the time of purchase in such names
and in such denominations as you shall specify.
Payment of the purchase price for
the Additional Shares shall be made at the additional time of
purchase in the same manner and at the same office as the payment
for the Firm Shares. Electronic transfer of the Additional Shares
shall be made to you at the additional time of purchase in such
names and in such denominations as you shall specify.
Deliveries of the documents
described in Section 9 hereof with respect to the purchase of
the Shares shall be made at the offices of Cravath,
Swaine & Moore LLP at 825 Eighth Avenue,
New York, NY 10019, at 9:00 A.M., New York City
time, on the date of the closing of the purchase of the Firm
Shares.
3. Representations and Warranties
of the Company. The Company represents and warrants to and
agrees with the Underwriter that:
(a) the Registration Statement has
heretofore become effective under the Act or, with respect to any
registration statement to be filed to register the offer and sale
of Shares pursuant to Rule 462(b) under the Act, will be filed
with the Commission and become effective under the Act no later
than 10:00 P.M., New York City time, on the date of
determination of the public offering price for the Shares; no stop
order of the Commission preventing or suspending the use of the
Basic Prospectus, the Pre-Pricing Prospectus, the Prospectus
Supplement or the Prospectus, or the effectiveness of the
Registration Statement, has been issued, and no proceedings for
such purpose have been instituted or, to the Company’s
knowledge, are contemplated by the Commission;
(b) the Registration Statement
complied when it became effective, complies as of the date hereof
and, as amended or supplemented, at the time of purchase, each
additional time of purchase, if any, and at all times during which
a prospectus is required by the Act to be delivered (whether
physically or through compliance with Rule 172 under the Act
or any similar rule) in connection with any sale of Shares, will
comply, in all material respects, with the requirements of the Act;
the conditions to the use of Form S-3 in connection with the
offering and sale of the Shares as contemplated hereby have been
satisfied; the Registration Statement meets, and the offering and
sale of the Shares as contemplated hereby complies with, in all
material respects the requirements of Rule 415 under the Act;
the Registration Statement did not, as of the Effective Time,
contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make
the statements therein not misleading; the Pre-Pricing Prospectus
complied, at the time it was filed with the Commission, and
complies as of the date hereof, in all material respects with the
requirements of the Act; at no time during the period that begins
on the earlier of the date of the Pre-Pricing Prospectus and the
date
4
[EXECUTION COPY]
the Pre-Pricing Prospectus was filed
with the Commission and ends at the time of purchase did or will
the Pre-Pricing Prospectus, as then amended or supplemented,
include an untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not
misleading, and at no time during such period did or will the
Pre-Pricing Prospectus, as then amended or supplemented, include an
untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not
misleading; the Basic Prospectus complied or will comply, as of its
date and the date it was or will be filed with the Commission,
complies as of the date hereof (if filed with the Commission on or
prior to the date hereof) and, at the time of purchase, each
additional time of purchase, if any, and at all times during which
a prospectus is required by the Act to be delivered (whether
physically or through compliance with Rule 172 under the Act
or any similar rule) in connection with any sale of Shares, will
comply, in all material respects, with the requirements of the Act;
at no time during the period that begins on the earlier of the date
of the Basic Prospectus and the date the Basic Prospectus was filed
with the Commission and ends at the time of purchase did or will
the Basic Prospectus, as then amended or supplemented, include an
untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not
misleading, and at no time during such period did or will the Basic
Prospectus, as then amended or supplemented, include an untrue
statement of a material fact or omit to state a material fact
necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading; each
of the Prospectus Supplement and the Prospectus will comply, as of
the date that it is filed with the Commission, the date of the
Prospectus Supplement, the time of purchase, each additional time
of purchase, if any, and at all times during which a prospectus is
required by the Act to be delivered (whether physically or through
compliance with Rule 172 under the Act or any similar rule) in
connection with any sale of Shares, in all material respects, with
the requirements of the Act (in the case of the Prospectus,
including, without limitation, Section 10(a) of the Act); at
no time during the period that begins on the earlier of the date of
the Prospectus Supplement and the date the Prospectus Supplement is
filed with the Commission and ends at the later of the time of
purchase, each additional time of purchase, if any, and the end of
the period during which a prospectus is required by the Act to be
delivered (whether physically or through compliance with
Rule 172 under the Act or any similar rule) in connection with
any sale of Shares did or will any Prospectus Supplement or the
Prospectus, as then amended or supplemented, include an untrue
statement of a material fact or omit to state a material fact
necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading;
provided , however , that the Company makes no
representation or warranty in this Section 3(b) with respect
to any statement contained in the Registration Statement, the
Pre-Pricing Prospectus or the Prospectus in reliance upon and in
conformity with information concerning the Underwriter and
furnished in writing by or on behalf of the Underwriter through you
to the Company expressly for use in the Registration Statement, the
Pre-Pricing Prospectus or the Prospectus; each Incorporated
Document, at the time such document was filed with the Commission
or at the time such document became effective, as applicable,
complied, in
5
[EXECUTION COPY]
all material respects, with the
requirements of the Exchange Act and did not include an untrue
statement of a material fact or omit to state a material fact
necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not
misleading;
(c) prior to the execution of this
Agreement, the Company has not, directly or indirectly, used any
“prospectus” (within the meaning of the Act) in
connection with the offer or sale of the Shares, in each case other
than the Pre-Pricing Prospectus;
(d) the Company has been duly
incorporated and is an existing corporation in good standing under
the laws of the Commonwealth of Pennsylvania, with corporate power
and authority to own its properties and conduct its business as
described in the Registration Statement, the Pre-Pricing Prospectus
and the Prospectus; and the Company is duly qualified to do
business as a foreign corporation in good standing in all other
jurisdictions in which its ownership or lease of property or the
conduct of its business requires such qualification, except where
the failure to be so qualified or in good standing would not,
individually or in the aggregate, have a material adverse effect on
the condition (financial or otherwise), business, properties,
prospects or results of operations of the Company and the
Subsidiaries (as defined below) taken as a whole (a “
Material Adverse Effect ”);
(e) each subsidiary of the Company
has been duly incorporated or formed and is an existing corporation
or other entity in good standing under the laws of the jurisdiction
of its incorporation or formation, with corporate power and
authority to own its properties and conduct its business as
described in the Registration Statement, the Pre-Pricing Prospectus
and the Prospectus; each Subsidiary is duly qualified to do
business as a foreign corporation or other entity in good standing
in all other jurisdictions in which its ownership or lease of
property or the conduct of its business requires such
qualification, except where the failure to be so qualified or to be
in good standing would not, individually or in the aggregate,
result in a Material Adverse Effect; all of the issued and
outstanding capital stock or other ownership interest of each of
the Subsidiaries has been duly authorized and validly issued and is
fully paid and nonassessable; the capital stock or other ownership
interest of the Subsidiaries is owned free from liens, encumbrances
and defects other than liens and encumbrances pursuant to Koppers
Inc.’s senior secured credit facility and senior secured
notes; and the entities listed on Schedule D annexed hereto
are the only subsidiaries, direct or indirect, of the Company
(collectively, the “ Subsidiaries ”);
(f) the Shares and all other
outstanding shares of capital stock of the Company have been duly
authorized and have been validly issued, fully paid and
nonassessable and conform, in all material respects, to the
description thereof contained or incorporated by reference in the
Registration Statement, the Pre-Pricing Prospectus and the
Prospectus; and the shareholders of the Company have no preemptive
rights with respect to the Shares;
(g) as of the date of this
Agreement, the Company has an authorized and outstanding
capitalization as set forth in the sections of the Registration
Statement, the
6
[EXECUTION COPY]
Pre-Pricing Prospectus and the
Prospectus entitled “Description of Capital Stock” and
“The Offering”, and, as of the time of purchase, the
Company shall have an authorized and outstanding capitalization as
set forth in the section of the Registration Statement, the
Pre-Pricing Prospectus and the Prospectus entitled
“Description of Capital Stock” and “The
Offering”;
(h) except as disclosed in the
Registration Statement, the Pre-Pricing Prospectus and the
Prospectus, there are no contracts, agreements or understandings
between the Company or any of its subsidiaries and any person that
would give rise to a valid claim against the Company, any of its
subsidiaries or the Underwriter for a brokerage commission,
finder’s fee or other like payment in connection with this
offering;
(i) except as disclosed in the
Registration Statement, the Pre-Pricing Prospectus and the
Prospectus, there are no contracts, agreements or understandings
between the Company or any of its subsidiaries and any person
granting such person the right to require the Company or any of its
subsidiaries to file a registration statement under the Act with
respect to any securities of the Company or any of its subsidiaries
or to require the Company or any of its subsidiaries to include
such securities in the securities registered pursuant to a
Registration Statement or in any securities being registered
pursuant to any other registration statement filed by the Company
under the Act;
(j) the Shares are duly listed, and
admitted and authorized for trading on the New York Stock Exchange
(the “ NYSE ”);
(k) no consent, approval,
authorization or order of, or filing with, any governmental agency
or body or any court is required to be obtained or made by the
Company for the consummation of the transactions contemplated by
this Agreement in connection with the sale of the Shares, except
such as have been obtained and made under the Act and such as may
be required under state securities laws;
(l) the execution, delivery and
performance of this Agreement, and the consummation of the
transactions herein contemplated will not result in a breach or
violation of any of the terms and provisions of, or constitute a
default under (A) any statute, any rule, regulation or order
of any governmental agency or body or any court, domestic or
foreign, having jurisdiction over the Company or any subsidiary of
the Company or any of their properties, (B) any agreement or
instrument to which the Company or any such subsidiary is a party
or by which the Company or any such subsidiary is bound or to which
any of the properties of the Company or any such subsidiary is
subject, or (C) the charter, by-laws or other organizational
document of the Company or any of the Subsidiaries, or except in
the case of clause (B), for such breaches, violations or defaults
that would not, individually or in the aggregate, have a Material
Adverse Effect;
(m) this Agreement has been duly
authorized, executed and delivered by the Company;
7
[EXECUTION COPY]
(n) except as disclosed in the
Registration Statement, the Pre-Pricing Prospectus and the
Prospectus, the Company and its subsidiaries have good and
marketable title to all real properties and all other properties
and assets owned by them, in each case free from liens,
encumbrances and defects that would materially affect the value
thereof or materially interfere with the use made or to be made
thereof by them; and except as disclosed in the Registration
Statement, the Pre-Pricing Prospectus and the Prospectus, the
Company and its subsidiaries hold any leased real or personal
property under valid and enforceable leases with no exceptions that
would materially interfere with the use made or to be made thereof
by them;
(o) each of the Company and the
Subsidiaries possess adequate certificates, authorities or permits
issued by appropriate governmental agencies or bodies necessary to
conduct the business now operated by them, except for such
certificates, authorities or permits the lack of which would not,
individually or in the aggregate, have a Material Adverse Effect,
and have not received any notice of proceedings relating to the
revocation or modification of any such certificate, authority or
permit that would, individually or in the aggregate, have a
Material Adverse Effect;
(p) no labor dispute with the
employees of the Company or any subsidiary exists or, to the
knowledge of the Company, is imminent that would reasonably be
expected to have a Material Adverse Effect;
(q) the Company and its Subsidiaries
own, possess, or can acquire on reasonable terms, adequate
trademarks, trade names and other rights to inventions, know-how,
patents, copyrights, confidential information and other
intellectual property (collectively, “ intellectual
property rights ”) necessary to conduct the business now
operated by them, or presently employed by them, and have not
received any notice of infringement of or conflict with asserted
rights of others with respect to any intellectual property rights
that would, individually or in the aggregate, have a Material
Adverse Effect;
(r) except as disclosed in the
Registration Statement, the Pre-Pricing Prospectus and the
Prospectus, the Company and the Subsidiaries and their properties,
assets and operations are in compliance with, and hold all permits,
authorizations and approvals required under, Environmental Laws (as
defined below), except to the extent that failure to so comply or
to hold such permits, authorizations or approvals would not be
reasonably expected to, individually or in the aggregate, have a
Material Adverse Effect; except as disclosed in the Registration
Statement, the Pre-Pricing Prospectus and the Prospectus, there are
no past, present or, to the Company’s knowledge, reasonably
anticipated future events, conditions, circumstances, activities,
practices, actions, omissions or plans that could reasonably be
expected to give rise to any material costs or liabilities to the
Company or any Subsidiary under, or to materially interfere with or
prevent compliance by the Company or any Subsidiary with,
Environmental Laws; except as disclosed in the Registration
Statement, the Pre-Pricing Prospectus and the Prospectus, neither
the Company nor any of the Subsidiaries (i) is the subject of
any investigation, (ii) has received any notice or claim,
(iii) is a party to or affected by any pending or threatened
action, suit or proceeding, (iv) is bound by any judgment,
decree or order or (v) has entered into any agreement, in each
case relating to any alleged violation
8
[EXECUTION COPY]
of any Environmental Law or an
alleged liability arising from or relating to any actual or alleged
release or threatened release or cleanup at any location of any
Hazardous Materials (as defined below) except as would not,
individually or in the aggregate, if determined adversely,
reasonably be expected to have a Material Adverse Effect (as used
herein, “ Environmental Law ” means any federal,
state, local or foreign law, statute, ordinance, rule, regulation,
order, decree, judgment, injunction, permit, license, authorization
or other binding requirement, or common law, relating to health,
safety or the protection, cleanup or restoration of the environment
or natural resources, including those relating to the distribution,
processing, generation, treatment, storage, disposal,
transportation, other handling or release or threatened release of,
or exposure to, Hazardous Materials, and “ Hazardous
Materials ” means any material (including, without
limitation, pollutants, contaminants, hazardous or toxic substances
or wastes) that is regulated by or may give rise to liability under
any Environmental Law);
(s) in the ordinary course of its
business, the Company and each of the Subsidiaries conducts a
periodic review of the effect of the Environmental Laws on their
respective business, operations and properties, for the purpose of
identifying and evaluating associated material costs and
liabilities (including, without limitation, any capital or
operating expenditures required for cleanup, other remedial
activities or compliance with the Environmental Laws or any permit,
license or approval issued under Environmental Laws and any
potential liabilities to third parties);
(t) except as disclosed in the
Registration Statement, the Pre-Pricing Prospectus and the
Prospectus, there are no pending actions, suits or proceedings
against or affecting the Company, any of the Subsidiaries or any of
their respective properties that would, individually or in the
aggregate, have a Material Adverse Effect, or would materially and
adversely affect the ability of the Company to perform its
obligations under this Agreement, or which are otherwise material
in the context of the sale of the Shares; and no such actions,
suits or proceedings are, to the Company’s knowledge,
threatened or contemplated;
(u) the financial statements of the
Company included or incorporated by reference in the Registration
Statement, the Pre-Pricing Prospectus and the Prospectus, together
with the related notes and schedules, present fairly in all
material respects the financial position of the Company and the
Subsidiaries as of the dates shown and their results of operations
and cash flows for the periods shown, and, except as otherwise
disclosed in the Registration Statement, the Pre-Pricing Prospectus
and the Prospectus, such financial statements have been prepared in
conformity with the generally accepted accounting principles in the
United States applied on a consistent basis; and all disclosures
contained or incorporated by reference in the Registration
Statement, the Pre-Pricing Prospectus and the Prospectus, regarding
“non-GAAP financial measures” (as such term is defined
by the rules and regulations of the Commission) comply with
Regulation G of the Exchange Act and Item 10 of
Regulation S-K under the Act, to the extent applicable;
(v) subsequent to the respective
dates as of which information is given in the Registration
Statement, the Pre-Pricing Prospectus and the Prospectus, in each
case excluding any amendments or supplements to the foregoing made
after the execution of
9
[EXECUTION COPY]
this Agreement, there has been no
(i) material adverse change, nor any development or event
involving a prospective material adverse change, in the condition
(financial or other), business, properties or results of operations
of the Company and the Subsidiaries taken as a whole, and
(ii) except as disclosed in the Registration Statement, the
Pre-Pricing Prospectus and the Prospectus, there has been no
dividend or distribution of any kind declared, paid or made by the
Company on any class of its capital stock;
(w) the Company is subject to the
reporting requirements of either Section 13 or
Section 15(d) of the Securities Exchange Act of 1934 and files
reports with the Commission on the Electronic Data Gathering,
Analysis, and Retrieval (EDGAR) system;
(x) the Company is not an
“investment company” as defined in the Investment
Company Act of 1940;
(y) Ernst & Young LLP,
who have reviewed the financial statements of the Company and the
Subsidiaries included in the Registration Statement, the
Pre-Pricing Prospectus and the Prospectus, are, to the best of our
knowledge, independent registered public accountants with respect
to the Company within the meaning of the Act and the applicable
published rules and regulations thereunder;
(z) the Company and each of the
Subsidiaries make and keep accurate books and records and maintain
a system of internal accounting controls sufficient to provide
reasonable assurance that (i) transactions are executed in
accordance with management’s general or specific
authorization; (ii) transactions are recorded as necessary to
permit preparation of financial statements in conformity with
generally accepted accounting principles and to maintain
accountability for assets; (iii) access to assets is permitted
only in accordance with management’s general or specific
authorization; and (iv) the recorded accountability for assets
is compared with existing assets at reasonable intervals and
appropriate action is taken with respect to any
differences;
(aa) the Company has established and
maintains and evaluates “disclosure controls and
procedures” (as such term is defined in Rule 13a-15 and
15d-15 under the Exchange Act) and “internal control over
financial reporting” (as such term is defined in
Rule 13a-15 and 15d-15 under the Exchange Act); such
disclosure controls and procedures are designed to ensure that
material information relating to the Company, including its
consolidated subsidiaries, is made known to the Company’s
Chief Executive Officer and its Chief Financial Officer by others
within those entities, and such disclosure controls and procedures
are effective to perform the functions for which they were
established; the Company’s independent auditors and the Audit
Committee of the Board of Directors of the Company have been
advised, based on the Company’s most recent evaluation of
such disclosure controls and procedures, of: (i) all
significant deficiencies, if any, in the design or operation of
internal controls which could adversely affect the Company’s
ability to record, process, summarize and report financial data;
and (ii) all fraud, if any, whether or not material, that
involves management or other employees who have a role in the
Company’s internal controls; all material weaknesses, if any,
in internal controls have been identified to the Company’s
independent auditors; except as disclosed
10
[EXECUTION COPY]
in the Registration Statement, the
Pre-Pricing Prospectus and the Prospectus, or since the date of the
most recent evaluation of such disclosure controls and procedures
and internal controls, there have been no significant changes in
internal controls or in other factors that could significantly
affect internal controls, including any corrective actions with
regard to significant deficiencies and material weaknesses; and the
Company is taking all necessary actions to ensure that, upon and at
all times after effectiveness of the Registration Statement, except
as disclosed in the Registration Statement, the Pre-Pricing
Prospectus and the Prospectus, the Company and its officers and
directors, in their capacities as such, will be in compliance in
all material respects with the provisions of the Sarbanes-Oxley Act
of 2002 (the “ Sarbanes-Oxley Act ”) and the
rules and regulations promulgated in connection therewith,
including provisions with respect to “internal control over
financial reporting” (as such term is defined in
Rules 13a-15 and 15d-15 under the Act), which are applicable
at such time to the Company;
(bb) the Company has provided you
true, correct, and complete copies of all documentation pertaining
to any extension of credit in the form of a personal loan made,
directly or indirectly, by the Company to any director or executive
officer of the Company, or to any family member or affiliate of any
director or executive officer of the Company; and since
July 30, 2002, the Company has not, directly or indirectly,
including through any subsidiary: (i) extended credit,
arranged to extend credit, or renewed any extension of credit, in
the form of a personal loan, to or for any director or executive
officer of the Company, or to or for any family member or affiliate
of any director or executive officer of the Company; or
(ii) made any material modification, including any renewal
thereof, to any term of any personal loan to any director or
executive officer of the Company, or any family member or affiliate
of any director or executive officer, which loan was outstanding on
July 30, 2002; and
(cc) (A) on or before the date
hereof, “lock-up” agreements, each substantially in the
form of Exhibit A hereto (“Lock-Up
Agreements”), relating to sales and certain other
dispositions of shares of Securities or certain other securities,
have been executed and delivered to the Underwriter by those
officers of the Company listed on Schedule E
.
In addition, any certificate signed
by any officer of the Company or any of the Subsidiaries and
delivered to the Underwriter or counsel for the Underwriter in
connection with the offering of the Shares shall be deemed to be a
representation and warranty by the Company, as to matters covered
thereby, to each Underwriter.
4. Representations and Warranties
of the Selling Stockholders. Each Selling Stockholder,
severally and not jointly with the other Selling Stockholders,
represents and warrants to the Underwriter that:
(a) all written information
furnished to the Company by the Selling Stockholder specifically
for use in the Registration Statement, the Pre-Pricing Prospectus
or the Prospectus (the “ Selling Stockholder
Information ”) complied and will comply in all material
respects with all applicable provisions of the Act; the
Registration Statement, as it relates to the Selling Stockholder
Information, did not, as of the Effective Time, contain an untrue
statement of a material fact or omit to state a material fact
required to
11
[EXECUTION COPY]
be stated therein or necessary to
make the statements therein not misleading; at no time during the
period that begins on the earlier of the date of the Pre-Pricing
Prospectus and the date the Pre-Pricing Prospectus was filed with
the Commission and ends at the time of purchase did or will the
Pre-Pricing Prospectus, as then amended or supplemented, as the
Pre-Pricing Prospectus relates to such Selling Stockholder
Information, include an untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were
made, not misleading, and at no time during such period did or will
the Pre-Pricing Prospectus, as then amended or supplemented, as it
relates to the Selling Stockholder Information, include an untrue
statement of a material fact or omit to state a material fact
necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading; at no
time during the period that begins on the earlier of the date of
the Prospectus and the date the Prospectus is filed with the
Commission and ends at the later
